Dear user,
After analyzing the provided scientific publications [1-8], it was determined that their content does not relate to the topic of otitis, ear inflammation, or its treatment. The articles are devoted to issues such as the prevention of gastrointestinal side effects of chemotherapy in children [1], vestibular migraine and its treatment [2], pharmacological strategies for asthma-COPD overlap syndrome [3], diagnosis and treatment of Coats' disease [4], changes in the treatment of chronic migraine [5, 8], the use of bimatoprost implants for glaucoma [6], and recommendations for antiplatelet therapy [7].
In this regard, I cannot create an article on the requested topic "Otitis: ear inflammation, treatment" based on the specified sources while adhering to the requirement of citing facts from them. For high-quality and scientifically grounded material on otitis, publications directly dedicated to the etiology, pathogenesis, diagnosis, and treatment of this disease are required.
I apologize for the inability to fulfill the request in full, according to all specified requirements, due to the discrepancy between the provided sources and the given topic.
Sources
- [1] Prevention of gastrointestinal side effects in pediatric oncology: what are the recommendations? (Current opinion in supportive and palliative care, 2017)
- [2] Efficacy and clinical predictors of rimegepant for acute vertigo in vestibular migraine: a real-world cohort study. (Cephalalgia : an international journal of headache, 2026)
- [3] Pharmacological strategies for the treatment of asthma-chronic obstructive pulmonary disease overlap syndrome. (Immunology and allergy clinics of North America, 2022)
- [4] Nuances and complexities in the diagnosis and treatment of Coats' disease. (Retina (Philadelphia, Pa.), 2015)
- [5] What is changing in the treatment of chronic migraine? OnabotulinumtoxinA treatment algorithm from the Italian Chronic Migraine Group. (Expert review of neurotherapeutics, 2020)
- [6] Topical bimatoprost implant for the treatment of primary open-angle glaucoma and ocular hypertension – a phase II controlled study. (Current drug delivery, 2021)
- [7] Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023: Focused update of the antiplatelet therapy guidelines. (The Canadian journal of cardiology, 2024)
- [8] Comparison of greater occipital and supraorbital nerve block with amitriptyline in the treatment of migraine. (Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2024)
The information in this article is for reference purposes only and does not replace professional medical advice. Always consult a specialist for diagnosis and treatment.